Horizon Kinetics Medical ETF Rating $28.38 +0.06 (+0.21%) As of 02/21/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsRatingsTrends Horizon Kinetics Medical ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.MEDX Aggregate RatingModerate Buy 2.70Holdings in MEDX have an aggregate rating of Moderate Buy based on 431 analyst ratings issued in the past year covering 32 companies (89.0% of the portfolio).MEDX Aggregate Price Target$28.39High Prediction$28.39Average Prediction$28.39Low Prediction$28.39Holdings in MEDX have an aggregate price target of $28.39 and a range of $28.39 to $28.39 covering 32 companies (89.0% of the portfolio).MEDX Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy5 Buy rating(s)Moderate Buy18 Moderate Buy rating(s)Hold9 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Horizon Kinetics Medical ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 32 MEDX Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings17.18%LLYEli Lilly and Company$874.12+0.1%4.8538 of 5 stars2.85$1,007.94 15.3%20Positive News8.97%ABBVAbbVie$202.03+0.6%4.6572 of 5 stars2.88$208.35 3.1%24Dividend AnnouncementAnalyst RevisionPositive News5.92%AMGNAmgen$303.01+1.7%4.4751 of 5 stars2.46$314.09 3.7%24Insider TradePositive News5.80%BMYBristol-Myers Squibb$55.85+0.1%4.5959 of 5 stars2.30$57.86 3.6%20Analyst RevisionPositive News5.56%AZNAstraZeneca$74.20-0.5%2.6758 of 5 stars3.10$89.75 21.0%10Options Volume5.01%ALKSAlkermes$35.33-0.5%3.6896 of 5 stars2.82$38.36 8.6%114.83%JNJJohnson & Johnson$162.35+1.7%4.4114 of 5 stars2.56$170.67 5.1%18Ex-DividendAnalyst ForecastOptions VolumePositive News4.47%ALNYAlnylam Pharmaceuticals$250.59-0.2%4.4628 of 5 stars2.72$299.48 19.5%25Analyst ForecastInsider Trade4.01%PFEPfizer$26.32+1.6%4.9993 of 5 stars2.50$31.92 21.3%16Options VolumePositive News3.38%MRKMerck & Co., Inc.$89.40+2.0%5 of 5 stars2.58$116.39 30.2%24Analyst DowngradeOptions Volume3.18%CRSPCRISPR Therapeutics$47.91-5.0%3.1691 of 5 stars2.50$74.40 55.3%22Analyst ForecastInsider TradeOptions VolumeAnalyst Revision2.94%REGNRegeneron Pharmaceuticals$700.33+0.6%4.6674 of 5 stars2.76$973.13 39.0%25Dividend Announcement2.59%BIIBBiogen$140.64+2.6%4.7515 of 5 stars2.43$211.85 50.6%30Analyst Forecast2.47%GSKGSK$36.62-0.9%3.2595 of 5 stars2.60$43.25 18.1%10Gap Down2.35%IONSIonis Pharmaceuticals$32.33-1.1%4.4271 of 5 stars2.70$60.00 85.6%20Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage1.88%BEAMBeam Therapeutics$30.43-8.2%3.1509 of 5 stars3.00$47.67 56.6%12Gap Up1.23%REPLReplimune Group$13.98-2.3%4.0934 of 5 stars3.13$19.29 38.0%8Gap Up1.09%BCYCBicycle Therapeutics$11.66-2.8%2.8366 of 5 stars2.75$29.43 152.4%8News Coverage0.93%NTLAIntellia Therapeutics$12.17-0.7%4.3943 of 5 stars2.72$48.71 300.2%18News CoverageGap Up0.87%LTRNLantern Pharma$4.330.4623 of 5 stars2.001News CoverageNegative News0.83%HLNHaleon$10.08+1.8%1.5972 of 5 stars2.71$10.95 8.7%7Positive News0.69%VNDAVanda Pharmaceuticals$4.43-1.3%4.1201 of 5 stars3.00$16.50 272.5%2Analyst ForecastAnalyst RevisionGap Down0.58%SDZNYSandoz Group$46.46-1.0%1.6689 of 5 stars2.003Gap Down0.54%GEHCGE HealthCare Technologies$91.09-1.1%3.2522 of 5 stars2.69$97.67 7.2%13Positive News0.46%GALTGalectin Therapeutics$1.49+1.4%1.6421 of 5 stars2.00$11.00 638.3%1Positive News0.27%TSVT2seventy bio$2.61-2.6%2.1813 of 5 stars2.50$7.20 175.9%6Analyst ForecastNews Coverage0.26%EDITEditas Medicine$1.92-7.0%4.6499 of 5 stars2.07$7.00 265.5%14Gap Up0.24%ALLOAllogene Therapeutics$2.17-4.0%2.8268 of 5 stars2.90$9.73 348.5%100.23%VTRSViatris$11.25+1.7%2.3344 of 5 stars2.00$13.67 21.5%3News Coverage0.13%PACBPacific Biosciences of California$1.54-6.1%2.3133 of 5 stars2.54$2.79 81.3%13Analyst ForecastOptions VolumeAnalyst RevisionNews CoverageGap Down0.08%BLUEbluebird bio$4.08-42.0%1.7446 of 5 stars2.00$49.14 1,104.5%9Options VolumeNews CoverageGap DownHigh Trading Volume0.06%MURAMural Oncology$4.05-4.0%3.5948 of 5 stars3.25$16.00 295.1%4 This page (NASDAQ:MEDX) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Horizon Kinetics Medical ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Horizon Kinetics Medical ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MEDX Stock Alerts